Search

Search Constraints

You searched for: Author/Creator Howard, Rachel

Search Results

4. COMP-13. EARLY TUMOR VOLUME EVOLUTION ADAPTIVELY PREDICTS PATIENT-SPECIFIC RESPONSE AND PROGRESSION RISK TO RADIOTHERAPY, PEMBROLIZUMAB, AND BEVACIZUMAB IN RECURRENT HIGH-GRADE GLIOMA IN A PHASE I TRIAL. (11th November 2019)

5. Considerations for treatment duration in responders to immune checkpoint inhibitors. Issue 3 (2nd March 2021)

9. Integrating Somatic and Germline Next-Generation Sequencing Into Routine Clinical Oncology Practice. (2021)

10. Longitudinal patient-reported outcomes and survival among early-stage non-small cell lung cancer patients receiving stereotactic body radiotherapy. (February 2022)